Key result
A case report discusses the possibilities for antithrombotic therapy in a 67-year-old patient with mild haemophilia A and atrial fibrillation.
Why the study?
How should antithrombotic therapy be managed in a patient with mild haemophilia A and atrial fibrillation?
Case Report (n=1)
How should antithrombotic therapy be managed in a patient with mild haemophilia A and atrial fibrillation?
Highlights the clinical challenge and management options for antithrombotic therapy in aging haemophilia patients with atrial fibrillation.
Individualized antithrombotic options may be feasible in mild haemophilia A with AF; leaves open optimal regimens pending prospective data.
The remarkable advances made in recent decades in the treatment of haemophilia have resulted in a longer life expectancy for haemophilia patients. The care of diseases related to ageing in these patients is becoming of great interest. We briefly discuss the current possibilities for antithrombotic therapy in patients with haemophilia describing the case of a 67-year-old patient with mild haemophilia A and atrial fibrillation requiring antithrombotic therapy.
No takes yet. Share an insight, caveat, or question.
Carlos Aguilar (2015) conducted a case report in Mild haemophilia A and atrial fibrillation (n=1). Antithrombotic therapy was evaluated. A case report discusses the possibilities for antithrombotic therapy in a 67-year-old patient with mild haemophilia A and atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: